Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal for Immunotherapy of Cancer|August 16, 2017
Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumabPhilip Friedlander, Karl Wassmann, Alan M Christenfeld, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 19, 2017
RAPID EVOLUTION OF THYROID DYSFUNCTION IN PATIENTS TREATED WITH NIVOLUMABGrenye O'Malley, Hanna J Lee, Samir Parekh, et al.
Cancer Treatment Reviews|February 6, 2025
Diagnosis and management of bispecific T cell-engaging antibody toxicity: A primer for emergency physiciansMonica K Wattana, Jonathan Rowland, Aiham Qdaisat, et al.
Oncolytic Virotherapy|August 12, 2016
Oncolytic virus therapy for cancerJoe Goldufsky, Shanthi Sivendran, Sara Harcharik, et al.
Melanoma Research|December 25, 2012
Elevated rates of transaminitis during ipilimumab therapy for metastatic melanomaSebastian G Bernardo, Marina Moskalenko, Michael Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2014
Blood mRNA expression profiling predicts survival in patients treated with tremelimumabYvonne Saenger, Jay Magidson, Bobby Liaw, et al.
Frontiers in Oncology|May 27, 2024
Case report: Regression of in-transit metastases of cutaneous squamous cell carcinoma with combination pembrolizumab and topical diphencyproneDina Poplausky, Jade N Young, Brandon R Block, et al.
American Journal of Otolaryngology|April 11, 2024
Metastatic merkel cell carcinoma to the thyroid gland: Case report and review of the literatureSalmaan Sayeed, Danielle Kapustin, Samuel J Rubin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2018
Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot TrialChrisann Kyi, Vladimir Roudko, Rachel Sabado, et al.
Frontiers in Oncology|May 30, 2024
Phase II trial of vaccination with autologous, irradiated melanoma cells engineered by adenoviral mediated gene transfer to secrete granulocyte-macrophage colony stimulating factor in patients with stage III and IV melanomaTamara A Sussman, Mariano Severgnini, Anita Giobbie-Hurder, et al.
Pageof 3